LAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Standard BioTools Inc (LAB) is not a good buy for a beginner, long-term investor at this time. The technical indicators are bearish, the financial performance shows significant declines, and there are no positive catalysts or strong trading signals to support an immediate investment decision.
The MACD is negative and expanding, RSI is neutral at 22.451, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1.024), with no clear upward momentum. The stock has a 100% chance of declining -0.81% in the next day and -2.98% in the next month.
NULL identified. There is no recent news or significant insider or hedge fund activity to act as a positive catalyst.
Technical indicators are bearish, and options data suggests bearish sentiment.
In Q4 2025, revenue dropped to $23.795M (-49.07% YoY), net income dropped to $19.283M (-156.59% YoY), and EPS dropped to 0.05 (-155.56% YoY). Gross margin increased slightly to 47.83% (+2.00% YoY), but overall financial performance is weak.
No recent analyst ratings or price target changes are available.
